The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Comparison of the effects of P2Y12 receptor antagonists on platelet function in patients undergoing primary PCI: a substudy of the HEAT-PPCI trial
EuroIntervention 2018;13:1931-1938 published online January 2018. DOI: 10.4244/EIJ-D-17-00408
Adeel Shahzad1*, MBBS, MRCP; Vikram Khanna2, MBBS, MRCP; Ian Kemp1, BA; Matthew Shaw1, BA; Christine Mars1, Dip HE; Robert Cooper1, MBBS, MRCP; Keith Wilson1; Nick Curzen2, BM (Hons), PhD, FRCP; Rod H. Stables1, MA (Cantab), DM (Oxon), BM, BCH (Oxon), FRCP
1. Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom; 2. University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
Aims: The HEAT-PPCI trial compared bivalirudin and unfractionated heparin in patients undergoing primary percutaneous coronary intervention (PPCI). The aim of this study was to report pre